ScreenerHero

QGENQIAGEN N.V.

NYSE · US · Healthcare · Diagnostics & Research · qiagen.com
44.07USDMkt Cap: 9.10B $P/E: 22.37

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification …

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$232.67BUSDP/E 33.9
DHR
Danaher Corporation
$153.85BUSDP/E 39.0
LONN
Lonza Group Ltd
$47.21BUSDP/E 38.3
NTRA
Natera, Inc.
$47.86BUSD
A
Agilent Technologies, Inc.
$44.91BUSDP/E 31.9
IDXX
IDEXX Laboratories, Inc.
$43.93BUSDP/E 39.1
IQV
IQVIA Holdings Inc
$42.77BUSDP/E 32.3
WAT
Waters Corporation
$40.32BUSDP/E 103.5
ILMN
Illumina, Inc.
$33.13BUSDP/E 41.0
MTD
Mettler-Toledo International, Inc.
$27.96BUSDP/E 31.5
LH
Labcorp Holdings Inc.
$27.28BUSDP/E 27.8
DGX
Quest Diagnostics Incorporated
$26.97BUSDP/E 26.0
GH
Guardant Health, Inc.
$22.91BUSD
MEDP
Medpace Holdings, Inc.
$17.33BUSDP/E 36.4
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$14.09BUSD
RVTY
Revvity Inc. Common Stock
$13.92BUSDP/E 59.7
ICLR
ICON Public Limited Company
$13.29BUSDP/E 269.1
BIM
bioMerieux S.A.
$9.55BUSDP/E 19.1
TWST
Twist Bioscience Corp.
$9.13BUSD

Key Statistics

Company
Market Cap9.10B $
Enterprise Value9.96B $
Revenue (TTM)2.10B $
Gross Profit1.30B $
Net Income (TTM)424.88M $
Revenue/Share10.16 USD
Last Price44.07 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5.5K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINNL0012169213
Valuation
P/E (Trailing)22.37
P/E (Forward)16.89
PEG1.11
EV/EBITDA13.57
EV/Revenue4.74
P/S4.33
P/B2.71
EPS (TTM)1.97
EPS (Forward)2.61
52W Range
43.7842% of range44.47
52W High44.47 USD
52W Low43.78 USD
Profitability
Gross Margin62.18%
Oper. Margin26.32%
EBITDA Margin34.96%
Profit Margin20.33%
ROE11.25%
ROA6.76%
Growth
Revenue Growth0.30%
Earnings Growth7.90%
Cash Flow & Leverage
Operating CF654.33M $
CapEx (TTM)207.13M $
FCF Margin17.75%
FCF Yield4.10%
Net Debt860.20M $
Net Debt/EBITDA1.17
Balance Sheet
Debt/Equity0.48
Current Ratio2.85
Quick Ratio2.05
Book Value/Sh16.26 USD
Cash/Share3.843 USD
Dividends
Fwd Div Rate0.3500 USD
Trail. Div Rate0.3630 USD
Div. Yield0.79%
5Y Avg Yield—
Payout Ratio17.79%
Ex-Div DateJul 7, 2026
Pay DateJul 14, 2026
Splits
Last Split962:1000
Split DateJan 25, 2017
Analyst Consensus
Rating2.2 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)46.07 USD
Upside (mean)+4.5%
Target Range40.00 USD – 50.00 USD
$40.00+4.5% to mean$50.00
# Analysts14
Ownership
Shares Out.206.50M
Float205.13M
Insiders0.48%
Institutions80.66%
Short Interest
Short Ratio2.9d
Short % Float4.51%
Short % Out.3.99%
Shares Short8.23M
Short (prev mo.)6.61M
Technical
SMA 5040.69 (+8.3%)
SMA 20042.76 (+3.1%)
Beta0.62
S&P 52W Chg19.18%
Avg Vol (30d)2.90M
Avg Vol (10d)3.60M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—